Genprex Inc
Research Genprex Inc (GNPX) on Bullrun: market cap USD 1.36M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGNPX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.36M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 4.45M
- Free cash flow-USD 5.14M
Valuation Snapshot
latest market cap is USD 1.36M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 16.23M | -USD 15.31M | n/a | -382.8 | USD 7.83M | n/a | USD 7.96M |
| FY2024 | USD 0 | -USD 21.39M | -USD 17.92M | n/a | -5871.58 | USD 1.60M | n/a | USD 1.62M |
| FY2023 | USD 0 | -USD 30.86M | -USD 24.81M | n/a | -24816 | USD 6.74M | n/a | USD 7.42M |
| FY2022 | USD 0 | -USD 23.74M | -USD 17.62M | n/a | -21780 | USD 20.95M | n/a | USD 22.27M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 1.36M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 5.76M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 9.25M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 13.66M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 69.60M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 62.62M | n/a | n/a | n/a |
About Genprex Inc
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Genprex Inc's market cap?
Genprex Inc's market capitalization is USD 1.36M.
What does Genprex Inc do?
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form.